Last 1,173 GBp
Change Today +84.00 / 7.71%
Volume 3.1M
SN/ On Other Exchanges
Symbol
Exchange
London
New York
OTC US
Frankfurt
Frankfurt
As of 7:35 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

smith & nephew plc (SN/) Snapshot

Open
1,180 GBp
Previous Close
1,089 GBp
Day High
1,195 GBp
Day Low
1,155 GBp
52 Week High
11/24/14 - 1,198 GBp
52 Week Low
12/31/13 - 850.00 GBp
Market Cap
10.5B
Average Volume 10 Days
2.6M
EPS TTM
0.56 GBp
Shares Outstanding
893.3M
EX-Date
10/23/14
P/E TM
32.4x
Dividend
0.29 GBp
Dividend Yield
1.61%
Current Stock Chart for SMITH & NEPHEW PLC (SN/)

Related News

No related news articles were found.

smith & nephew plc (SN/) Related Businessweek News

No Related Businessweek News Found

smith & nephew plc (SN/) Details

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.

14,000 Employees
Last Reported Date: 10/30/14
Founded in 1856

smith & nephew plc (SN/) Top Compensated Officers

Chief Executive Officer, Director, Chairman o...
Total Annual Compensation: $4.2M
Chief Financial Officer, Director and Member ...
Total Annual Compensation: $2.0M
Compensation as of Fiscal Year 2013.

smith & nephew plc (SN/) Key Developments

Stryker Reportedly Plans Offer For Smith & Nephew

Stryker Corporation (NYSE:SYK) is planning a takeover offer for Smith & Nephew plc (LSE:SN.), according to people with knowledge of the matter. Stryker plans to offer a significant premium to Smith & Nephew’s current share price, with one of the people saying it could be about 30%. Stryker is not planning a tax inversion because of the limited tax benefits and political risk, said one of the people, who asked not to be identified because deliberations are private, reported Bloomberg. The bid is still being finalized and the timing could change, said the people. There’s also a chance that Stryker may decide against an offer, one of the people said. Representatives for Stryker and Smith & Nephew declined to comment, reported Bloomberg.

Styker Reportedly To Bid $15 Billion For Smith

Stryker Corporation (NYSE:SYK) is reportedly looking to make a $15 billion offer for Smith & Nephew plc (LSE:SN.). Stryker made a commitment in May 2014, not to pursue the acquisition of Smith & Nephew for next six months after the Financial Times reported at the time it was working on a bid, Bloomberg reported. The six month period ends this week.

Smith & Nephew Signs $800 Million Private Placement

Smith & Nephew announced that it has signed a private placement agreement to borrow $800 million of long-term debt, comprising $730 million of fixed rate debt and $70 million of floating rate debt. The fixed debt has an average rate of 3.1% and an average maturity of just over eight years. The funds will be used to repay existing bank debt.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SN/:LN 1,173.00 GBp +84.00

SN/ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr515.50 DKK -5.50
CR Bard Inc $168.40 USD -0.70
Edwards Lifesciences Corp $129.90 USD -0.85
Olympus Corp ¥4,425 JPY -30.00
St Jude Medical Inc $66.47 USD -0.20
View Industry Companies
 

Industry Analysis

SN/

Industry Average

Valuation SN/ Industry Range
Price/Earnings 32.6x
Price/Sales 3.6x
Price/Book 4.1x
Price/Cash Flow 32.4x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC, please visit www.smith-nephew.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.